Validation of the Paediatric Food Allergy Quality of Life Questionnaire (PFA-QL)

Rebecca C Knibb1, Nur F Ibrahim, Rachel Petley

  • 1Department of Psychology, Faculty of Education Health and Sciences, University of Derby, Derby, UK. r.c.knibb@derby.ac.uk

Insights

The Paediatric Food Allergy Quality of Life Questionnaire (PFA-QL) and its parent version (PFA-QL-PF) are reliable and valid tools for assessing quality of life in children with food allergies. These UK-developed scales offer a culturally specific option for research and clinical practice.

Area of Science:

  • Pediatric Allergy and Immunology
  • Health-Related Quality of Life Research
  • Psychometric Validation Studies

Background:

  • The Paediatric Food Allergy Quality of Life Questionnaire (PFA-QL) was the first tool developed to assess health-related quality of life (QoL) in children with food allergies.
  • Despite its use in numerous studies, the PFA-QL has not undergone formal validation.

Purpose of the Study:

  • To validate the child (PFA-QL) and parent-proxy (PFA-QL-PF) versions of the PFA-QL.
  • To assess the reliability and validity of these tools in both specialist allergy clinic and general population settings.

Main Methods:

  • 103 children (aged 6–16) with peanut or tree nut allergy completed the PFA-QL and a generic QoL scale (PedsQL).
  • Test-retest reliability of the PFA-QL was assessed in 50 stable patients.
  • 756 parents of food-allergic children completed the PFA-QL-PF and other validated questionnaires measuring child health and parental burden.

Main Results:

  • Both PFA-QL and PFA-QL-PF demonstrated good internal consistency (Cronbach's alpha 0.77–0.82).
  • Moderate to good agreement was found between the PFA-QL and generic QoL measures.
  • The PFA-QL showed stability over time, and girls reported poorer QoL than boys in both samples.

Conclusions:

  • The PFA-QL and PFA-QL-PF are reliable and valid instruments for assessing QoL in children with food allergies.
  • These UK-developed and validated tools provide a culturally relevant option for research, clinical trials, and practice within the UK.
  • Further validation studies in international populations are recommended.
Abstract

Related Concept Videos